Speaker Profile
Ph.D., SVP, Medical Affairs, GeneDx
Biography
Britt oversees research collaborations, clinical data analysis, science writing, publications, and research strategy at GeneDx— all in service of expanding access to genomic testing, reducing the diagnostic odyssey for patients with rare disease, and improving their clinical outcomes.
Her career has been shaped by the conviction that genomic information is essential to healthcare decision-making — not only delivering diagnoses but meaningfully guiding clinical management. Prior to GeneDx, she held broad leadership roles at Invitae Corporation, including directing U.S. Medical Affairs, leading clinical genomics reporting teams, designing inherited metabolic and immunology testing menus, and supporting platform innovations spanning machine learning, MAVEs, and RNAseq. Earlier, she served as Technical Director of the Clinical Biochemical Genetics Diagnostic Laboratory at the University of Miami, a confirmatory newborn screening center for Florida, where she also built a sponsored testing program for patients with lysosomal storage diseases in Latin America.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Wendy Chung, Boston Children's / Harvard
PMWC Award Ceremony
• Wendy Chung, Boston Children's / Harvard (Pioneer)
• Eric Lander, Broad Institute (Pioneer)
Featured Speakers
• Wendy Chung, Boston Children's / Harvard
• Eric Lander, Broad Institute
• Zhanzhi (Mike) Hu, Project GUARDIAN / Columbia
• Tippi MacKenzie, UCSF
• Ryan Taft, Genetic Alliance
• Heidi Cope, RTI International
• Michele Caggana, NY State DOH Wadsworth Center
• Elad Ziv, UCSF
• Scott Grosse, University of Minnesota
• Mike Talkowski, Mass General / Harvard
• F. Sessions Cole, WashU
• Lee Hood, Phenome Health / ISB
• Trey Ideker, UC San Diego
• Ralph Snyderman, Duke
• Craig Mundie, Mundie & Associates
• George Church, Harvard
Beyond the Exome: Solving Undiagnosed Disease
The next layer of rare-disease diagnosis beyond standard sequencing.
Population Genomic Screening
From newborn sequencing to implementation, evidence, economics, and equity.
Structural Variants & Long Reads
Solving cases missed by conventional sequencing.
Launching the Human Phenome Initiative
From genome to phenome as a global health infrastructure challenge.
Data-Driven Health
AI, longitudinal data, and personalized clinical medicine.
Engineering the Future of Health
Genomes, cells, and engineering biology as precision medicine moves upstream.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
